Compare drug alternatives

Dupixent® Alternatives

Dupixent®

(Dupilumab)
Dupixent
Prescription Only

Dupixent is an injectable medication that is typically administered subcutaneously every other week to treat inflammatory conditions, such as asthma and eczema, among others. Injection site reactions and eye conditions are the most frequently reported side effects. The risk of infection is low with Dupixent, unlike other biologics.

Dupixent is FDA approved for the following indications: Atopic Dermatitis, Asthma, Chronic Rhinosinusitis with Nasal Polyposis, Eosinophilic Esophagitis, Prurigo Nodularis.

Stelara®

(Ustekinumab)
Stelara
Prescription Only

Stelara is an immunosuppressant medication that targets two inflammatory cytokines, IL-12 and IL-23, which are key contributors to chronic inflammation. For Crohn's disease and ulcerative colitis, Stelara is administered every 8 weeks, and for psoriasis, it is given every 12 weeks. Its most frequently reported side effects are an increased susceptibility to infection, as well as nasopharyngitis, headache, and fatigue.

Stelara is FDA approved for the following indications: Plaque Psoriasis, Psoriatic Arthritis, Crohn’s Disease, and Ulcerative Colitis.

Dosage & Administration

Administration
Subcutaneous injection. Learn more.
Subcutaneous injection. Learn more.
Dosing
150 mg at Week 0, Week 4, and every 12 weeks thereafter.
45 mg initially and 4 weeks later, followed by 45 mg every 12 weeks for adult Psoriatic Arthritis. Weight-based dosing for pediatric Psoriatic Arthritis
Latin Shorthand
150 mg Week 0, 4 then q12w
45 mg Week 0, 4, then 45 mg q12w

Financial Assistance

Copay
$5
$5
Annual Cap
$6,000
Assistance Expiration
End of each calendar year (subject to change or discontinuation without notice)
Generics
No lower-cost generic available
No lower-cost generic available

Popular alternatives

Relevant Resources

Stelara
Dupixent